These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 7979307

  • 1. Increased activity of a new chlorofluoroquinolone, BAY y 3118, compared with activities of ciprofloxacin, sparfloxacin, and other antimicrobial agents against anaerobic bacteria.
    Aldridge KE.
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1671-4. PubMed ID: 7979307
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of Bay Y3118 against anaerobic bacteria.
    Wexler HM, Molitoris E, Finegold SM.
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2509-13. PubMed ID: 8285647
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria.
    García-Rodríguez JA, García-Sánchez JE, Trujillano-Martín I, García-Sánchez E, García-García MI, Fresnadillo-Martínez MJ.
    J Chemother; 1995 Jun; 7(3):189-96. PubMed ID: 7562012
    [Abstract] [Full Text] [Related]

  • 4. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
    Pankuch GA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1649-54. PubMed ID: 8215278
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria.
    Nord CE.
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S15-8. PubMed ID: 8953101
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria.
    Nord CE, Lindmark A, Persson I.
    Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):640-2. PubMed ID: 8223667
    [Abstract] [Full Text] [Related]

  • 7. In vitro activities of three of the newer quinolones against anaerobic bacteria.
    Wexler HM, Molitoris E, Finegold SM.
    Antimicrob Agents Chemother; 1992 Jan; 36(1):239-43. PubMed ID: 1317149
    [Abstract] [Full Text] [Related]

  • 8. Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria.
    Edlund C, Sabouri S, Nord CE.
    Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):193-5. PubMed ID: 9665302
    [Abstract] [Full Text] [Related]

  • 9. The in-vitro activity of Bay y 3118, a new chlorofluoroquinolone.
    Wise R, Andrews JM, Brenwald N.
    J Antimicrob Chemother; 1993 Jan; 31(1):73-80. PubMed ID: 8383104
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of BAY 12-8039, a new fluoroquinolone.
    Woodcock JM, Andrews JM, Boswell FJ, Brenwald NP, Wise R.
    Antimicrob Agents Chemother; 1997 Jan; 41(1):101-6. PubMed ID: 8980763
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of DU-6859a against anaerobic bacteria.
    Wexler HM, Molitoris E, Reeves D, Finegold SM.
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2504-9. PubMed ID: 7840599
    [Abstract] [Full Text] [Related]

  • 12. Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria.
    Goldstein EJ, Citron DM.
    Antimicrob Agents Chemother; 1992 May; 36(5):1158-62. PubMed ID: 1324640
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria.
    Wexler HM, Molitoris E, Reeves D, Finegold SM.
    J Antimicrob Chemother; 1994 Oct; 34(4):579-84. PubMed ID: 7868409
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility of anaerobic bacteria to PD 131628.
    Nord CE, Hagelbäck A.
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):68-71. PubMed ID: 1314176
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria.
    Liebetrau A, Rodloff AC, Behra-Miellet J, Dubreuil L.
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3667-71. PubMed ID: 14576144
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of gemifloxacin (SB 265805) against anaerobes.
    Goldstein EJ, Citron DM, Warren Y, Tyrrell K, Merriam CV.
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2231-5. PubMed ID: 10471570
    [Abstract] [Full Text] [Related]

  • 20. In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.
    Wexler HM, Molitoris E, Molitoris D, Finegold SM.
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2232-5. PubMed ID: 8878617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.